Co-Diagnostics (NASDAQ:CODX) announces
that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing in
India, has become the first and only Indian company to receive a
license from the Central Drugs Standards Control Organisation (CDSCO) to
manufacture RT-PCR COVID-19 test kits.
The kits will be sold in the Indian market, as well as for export to the surrounding regions.
The CDSCO approved COVID-19 test kits were
originally designed by Co-Diagnostics, the first U.S. company to receive
a CE marking for a COVID-19 diagnostic.
Shares are up 12% premarket.
https://seekingalpha.com/news/3553242-co-diagnostics-jv-cosara-receives-license-for-covidminus-19-diagnostic-shares-up-12-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.